Chemotherapy free treatment of indolent lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2395
Abstract: Advances in lymphoma biology have led to the identification of numerous new pathways and therapeutic targets that have the potential to significantly innovate treatment. The long natural history of indolent Non‐Hodgkin lymphoma (NHL), waxing and… read more here.
Keywords: chemotherapy; lymphoma; treatment; indolent ... See more keywords
Excellent Response to Very Low Dose Radiation (4Gy) For Indolent B-cell Lymphomas: Is 4Gy Suitable for Curable Patients?
Sign Up to like & getrecommendations! Published in 2021 at "Blood advances"
DOI: 10.1182/bloodadvances.2021004939
Abstract: Radiotherapy plays an important role in managing highly radiosensitive, indolent non-Hodgkin lymphomas (iNHL), such as follicular lymphoma (FL) and marginal zone lymphoma (MZL). While the standard of care for localized iNHL remains 24Gy, de-escalation to… read more here.
Keywords: vldrt; low dose; response; excellent response ... See more keywords
Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma
Sign Up to like & getrecommendations! Published in 2023 at "Upsala Journal of Medical Sciences"
DOI: 10.48101/ujms.v128.9392
Abstract: Background Increased microvascular density correlates with more advanced disease and unfavorable overall survival in non-Hodgkin lymphoma (NHL), suggesting that angiogenesis is important for disease progression. However, studies of anti-angiogenic agents in NHL patients, have generally… read more here.
Keywords: endostatin; lymphoma; plasma endostatin; indolent ... See more keywords